1.The Effect of Environmental Tobacco Smoke Exposure and Glutathione S-Transferase Polymorphism on Childhood Behavioral Development during Mid-Pregnancy and Early Childhood.
Jooyoun SONG ; Hye Ah LEE ; Minkyung KIM ; Hwayoung LEE ; Eun Ae PARK ; Hyesook PARK ; Kyu Wol YUN ; Eui Jung KIM
Journal of Korean Neuropsychiatric Association 2011;50(6):465-475
OBJECTIVES: The author investigated the relationship between the environmental tobacco smoke exposure during mid-pregnancy and early childhood and neurobehavioral outcomes of preschool children and if there is any effect of the genetic polymorphism of glutathione S-transferase (GST) M1 and T1 on this relationship. METHODS: The participants were the pregnant women (week 24-28) who visited the obstetrics and gynecology department (between 2001 and 2004). They had been evaluated for their sociodemographic data including direct and environmental tobacco smoke exposure history and the urine specimen had been sampled for the measurement of cotinine. The offsprings' urine specimen and blood sampling had been done and the socioeconomic data including the environmental tobacco smoke exposure history was evaluated at age 3. The cotinine level of urine specimen was measured and GST polymorphism was analyzed. The offsprings completed Korean-Childhood Behavioral Check List (K-CBCL) at age 4-5. RESULTS: The environmental tobacco smoke exposure during mid-pregnancy based on urine cotinine level has a significant association with increased total score and externalizing problem score of K-CBCL (p<0.05). The environmental tobacco smoke exposure based on urine cotinine level at age 3 is associated increased total score, externalizing problem score and internalizing problem score of K-CBCL with no statistical significance. The environmental tobacco smoke exposure after controlling for tobacco smoke exposure during pregnancy, however, is significantly associated with the increased externalizing problem scores (p=0.04). The environmental tobacco smoke exposure is associated with increased total score, externalizing problem score and internalizing problem score of K-CBCL with GSTM1 null type or GSTT1 null type at age 3 although there was no statistical significance. CONCLUSION: The environmental tobacco smoking exposure during pregnancy and at early childhood is associated with childhood behavioral problems. The clinical implication of this study is that it is important to avoid the environmental tobacco smoke exposure during pregnancy and early childhood and to monitor the possible emergence of behavioral problems of children.
Child
;
Child, Preschool
;
Cotinine
;
Female
;
Glutathione
;
Glutathione Transferase
;
Gynecology
;
Humans
;
Obstetrics
;
Organothiophosphorus Compounds
;
Polymorphism, Genetic
;
Pregnancy
;
Pregnant Women
;
Smoke
;
Smoking
;
Tobacco
2.Impact of Enzyme Replacement Therapy on Linear Growth in Korean Patients with Mucopolysaccharidosis Type II (Hunter Syndrome).
Sung Yoon CHO ; Rimm HUH ; Mi Sun CHANG ; Jieun LEE ; Younghee KWUN ; Se Hyun MAENG ; Su Jin KIM ; Young Bae SOHN ; Sung Won PARK ; Eun Kyung KWON ; Sun Ju HAN ; Jooyoun JUNG ; Dong Kyu JIN
Journal of Korean Medical Science 2014;29(2):254-260
Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency in the lysosomal enzyme iduronate-2-sulfatase. Short stature is a prominent and consistent feature in MPS II. Enzyme replacement therapy (ERT) with idursulfase (Elaprase(R)) or idursulfase beta (Hunterase(R)) have been developed for these patients. The effect of ERT on the growth of Korean patients with Hunter syndrome was evaluated at a single center. This study comprised 32 patients, who had received ERT for at least 2 yr; they were divided into three groups according to their ages at the start of ERT: group 1 (<6 yr, n=14), group 2 (6-10 yr, n=11), and group 3 (10-20 yr, n=7). The patients showed marked growth retardation as they got older. ERT may have less effect on the growth of patients with the severe form of Hunter syndrome. The height z-scores in groups 2 and 3 revealed a significant change (the estimated slopes before and after the treatment were -0.047 and -0.007, respectively: difference in the slope, 0.04; P<0.001). Growth in response to ERT could be an important treatment outcome or an endpoint for future studies.
Adolescent
;
Body Height
;
Child
;
Child, Preschool
;
Demography
;
Enzyme Replacement Therapy
;
Humans
;
Iduronate Sulfatase/*therapeutic use
;
Infant
;
Male
;
Mild Cognitive Impairment/etiology
;
Mucopolysaccharidosis II/complications/diagnosis/*therapy
;
Mutation
;
Phenotype
;
Protein Isoforms/therapeutic use
;
Republic of Korea
;
Young Adult